Literature DB >> 27496380

Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.

Dan Li1, Yajin Liu2, Xu Zhang2, Huizhen Lv2, Wei Pang1, Xiaoli Sun1, Li-Ming Gan3, Bruce D Hammock4, Ding Ai2, Yi Zhu5.   

Abstract

RATIONALE: Circulating monocytes play pivotal roles in chronic inflammatory diseases. Epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid, are known to have anti-inflammatory effects and are hydrolyzed by soluble epoxide hydrolase (sEH).
OBJECTIVE: We aimed to investigate the effect of sEH inhibition in atherogenesis. METHODS AND
RESULTS: Mice with low-density lipoprotein receptor deficiency (Ldlr(-/-)) with or without sEH inhibitor, and Ldlr/sEH double-knockout (DK) mice were fed a Western-type diet (WTD) for 6weeks to induce arteriosclerosis. Both sEH inhibition and gene depletion decreased the WTD-induced hyperlipidemia, plaque area and macrophage infiltration in mice arterial wall. Ly6C(hi) infiltration of monocytes remained similar in blood, spleen and bone marrow of DK mice, but was decreased in aortic lesions. To further assess the role of sEH or EETs in monocyte/macrophage infiltration in atherogenesis, we transplanted DK bone marrow into Ldlr(-/-) recipients, and then fed mice the WTD. Aortic lesions and Ly6C(hi) monocyte infiltration were reduced in mice with transplanted bone marrow of DK mice without diminishing the cholesterol level. Furthermore, sEH inhibition or gene depletion increased the ratio of EETs/DHETs and diminished the expression of P-selectin glycoprotein ligand 1 (PSGL-1) in mice peripheral-blood mononuclear cells. Monocyte adhesion to P-selectin and to tumor necrosis factor α-activated endothelial cells was also diminished by sEH inhibition.
CONCLUSION: sEH inhibition and gene depletion attenuated atherosclerosis in mice by decreasing the infiltration of monocytes into the artery wall. EET and PSGL-1 may play pivotal roles in monocyte/macrophage infiltration and atherogenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Epoxyeicosatrienoic acids; Inflammation; Macrophage; Monocyte; P-selectin glycoprotein ligand-1; Soluble epoxide hydrolase

Mesh:

Substances:

Year:  2016        PMID: 27496380      PMCID: PMC5559083          DOI: 10.1016/j.yjmcc.2016.08.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  29 in total

1.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.

Authors:  John D Imig; Xueying Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

2.  Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.

Authors:  John D Imig; Xueying Zhao; Jorge H Capdevila; Christophe Morisseau; Bruce D Hammock
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

3.  Systematic metabolomic analysis of eicosanoids after omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography-tandem mass spectrometry-based method.

Authors:  Xu Zhang; Nan Yang; Ding Ai; Yi Zhu
Journal:  J Proteome Res       Date:  2015-03-17       Impact factor: 4.466

4.  In vivo regulation of Bcl6 and T follicular helper cell development.

Authors:  Amanda C Poholek; Kyle Hansen; Sairy G Hernandez; Danelle Eto; Anmol Chandele; Jason S Weinstein; Xuemei Dong; Jared M Odegard; Susan M Kaech; Alexander L Dent; Shane Crotty; Joe Craft
Journal:  J Immunol       Date:  2010-06-02       Impact factor: 5.422

Review 5.  Making a difference: monocyte heterogeneity in cardiovascular disease.

Authors:  Ingo Hilgendorf; Filip K Swirski
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 6.  Soluble epoxide hydrolase in atherosclerosis.

Authors:  Yi-Xin Jim Wang; Arzu Ulu; Le-Ning Zhang; Bruce Hammock
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

7.  Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.

Authors:  Ying Wang; Gary Z Wang; Peter S Rabinovitch; Ira Tabas
Journal:  Circ Res       Date:  2013-12-02       Impact factor: 17.367

Review 8.  P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall.

Authors:  Yuqing Huo; Lijun Xia
Journal:  Trends Cardiovasc Med       Date:  2009-05       Impact factor: 6.677

9.  L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes.

Authors:  Michael Freeley; Francis O'Dowd; Toby Paul; Dmitry Kashanin; Anthony Davies; Dermot Kelleher; Aideen Long
Journal:  J Immunol       Date:  2012-05-11       Impact factor: 5.422

10.  RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1.

Authors:  K Ponnusamy; N Kohrs; A Ptasinska; S A Assi; T Herold; W Hiddemann; J Lausen; C Bonifer; R Henschler; C Wichmann
Journal:  Oncogenesis       Date:  2015-04-13       Impact factor: 7.485

View more
  12 in total

1.  Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.

Authors:  Yajin Liu; Xuan Fang; Xu Zhang; Jing Huang; Jinlong He; Liyuan Peng; Chenji Ye; Yingmei Wang; Fengxia Xue; Ding Ai; Dan Li; Yi Zhu
Journal:  Br J Pharmacol       Date:  2017-09-05       Impact factor: 8.739

Review 2.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

3.  Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

Authors:  Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

Review 4.  Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.

Authors:  John D Imig
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

5.  Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia.

Authors:  İsmail Sarı; Hatice Ökten; Çağdaş Aktan; Esra Cihan
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

6.  The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.

Authors:  Chih-Chan Lien; Chia-Hui Chen; Yeng-Ming Lee; Bei-Chia Guo; Li-Ching Cheng; Ching-Chien Pan; Song-Kun Shyue; Tzong-Shyuan Lee
Journal:  J Cell Mol Med       Date:  2019-08-22       Impact factor: 5.310

Review 7.  Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.

Authors:  Cheng-Peng Sun; Xin-Yue Zhang; Christophe Morisseau; Sung Hee Hwang; Zhan-Jun Zhang; Bruce D Hammock; Xiao-Chi Ma
Journal:  J Med Chem       Date:  2020-12-28       Impact factor: 7.446

8.  Inhibition of miR-200b-3p alleviates lipid accumulation and promotes cholesterol efflux by targeting ABCA1 in macrophage-derived foam cells.

Authors:  Yu-Ting Wu; Jiang-Bin Li; Hui-Qin Lin; Guo-Xin Zhang; Cong-Min Hong; Ming Li; Zhi-Jun Guo; Yan-Bing Yang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

9.  The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR-/- mice.

Authors:  Binglin Li; Xin Lu; Jia Wang; Xiaodong He; Quliang Gu; Lijing Wang; Yongxia Yang
Journal:  Int J Biol Sci       Date:  2018-01-01       Impact factor: 6.580

Review 10.  Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps.

Authors:  Jeffrey Warner; Josiah Hardesty; Kara Zirnheld; Craig McClain; Dennis Warner; Irina Kirpich
Journal:  Biology (Basel)       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.